Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective.


Journal

Prehospital and disaster medicine
ISSN: 1945-1938
Titre abrégé: Prehosp Disaster Med
Pays: United States
ID NLM: 8918173

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 16 7 2021
medline: 26 11 2021
entrez: 15 7 2021
Statut: ppublish

Résumé

Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specific infection prevention and control strategies to minimize the risk of transmission when planning MGEs. This literature review aimed to identify and analyze papers relating to novel respiratory viruses with pandemic potential and to inform MGE planning. This paper used a systematic literature review method. Various health care databases were searched using keywords relating to MGEs and novel respiratory viruses. Information was extracted from identified papers into various tables for analysis. The analysis identified infection prevention and control strategies used at MGEs to inform planning before, during, and following events. In total, 27 papers met the criteria for inclusion. No papers were identified regarding SARS-CoV-1, while the remainder reported on H1N1pdm09 (n = 9), MERS-CoV (n = 15), and SARS-CoV-2 (n = 3). Various before, during, and after event mitigation strategies were identified that can be implemented for future events. This literature review provided an overview of the novel respiratory virus epidemiology at MGEs alongside related public health mitigation strategies that have been implemented at these events. This paper also discusses the health security of event participants and host communities in the context of cancelling, postponing, and modifying events due to a novel respiratory virus. In particular, ways to recommence events incorporating various mitigation strategies are outlined.

Sections du résumé

BACKGROUND BACKGROUND
Mass-gathering events (MGEs) occur regularly throughout the world. As people congregate at MGEs, there is an increased risk of transmission of communicable diseases. Novel respiratory viruses, such as Severe Acute Respiratory Syndrome Coronavirus-1 (SARS-CoV-1), Influenza A Virus Subtype H1N1 Strain 2009 (H1N1pdm09), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), or Coronavirus Disease 2019 (COVID-19), may require specific infection prevention and control strategies to minimize the risk of transmission when planning MGEs. This literature review aimed to identify and analyze papers relating to novel respiratory viruses with pandemic potential and to inform MGE planning.
METHOD METHODS
This paper used a systematic literature review method. Various health care databases were searched using keywords relating to MGEs and novel respiratory viruses. Information was extracted from identified papers into various tables for analysis. The analysis identified infection prevention and control strategies used at MGEs to inform planning before, during, and following events.
RESULTS RESULTS
In total, 27 papers met the criteria for inclusion. No papers were identified regarding SARS-CoV-1, while the remainder reported on H1N1pdm09 (n = 9), MERS-CoV (n = 15), and SARS-CoV-2 (n = 3). Various before, during, and after event mitigation strategies were identified that can be implemented for future events.
CONCLUSIONS CONCLUSIONS
This literature review provided an overview of the novel respiratory virus epidemiology at MGEs alongside related public health mitigation strategies that have been implemented at these events. This paper also discusses the health security of event participants and host communities in the context of cancelling, postponing, and modifying events due to a novel respiratory virus. In particular, ways to recommence events incorporating various mitigation strategies are outlined.

Identifiants

pubmed: 34261546
pii: S1049023X21000662
doi: 10.1017/S1049023X21000662
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Pagination

599-610

Auteurs

Jamie Ranse (J)

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
School of Nursing and Midwifery, Griffith University, Gold Coast, Queensland, Australia.
Department of Emergency Medicine, Gold Coast Health, Gold Coast, Queensland, Australia.

Deborah Beckwith (D)

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
School of Nursing and Midwifery, Griffith University, Gold Coast, Queensland, Australia.

Anas Khan (A)

Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.

Saber Yezli (S)

Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.

Attila J Hertelendy (AJ)

Fellowship in Disaster Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA.
Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.
College of Business, Florida International University, Miami, FloridaUSA.

Alison Hutton (A)

School of Nursing and Midwifery, The University of Newcastle, Newcastle, New South Wales, Australia.

Peta-Anne Zimmerman (PA)

Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
School of Nursing and Midwifery, Griffith University, Gold Coast, Queensland, Australia.
Department of Infection Control, Gold Coast Health, Gold Coast, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH